aTYR PHARMA INC 4
4 · aTYR PHARMA INC · Filed Sep 22, 2016
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
King David John
See Remarks
Transactions
- Award
Employee Stock Option (right to buy)
2016-09-21+145,000→ 145,000 totalExercise: $3.29Exp: 2026-09-21→ Common Stock (145,000 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to this option shall vest and become exercisable on September 21, 2017, and the remainder shall thereafter vest in 36 equal monthly installments, such that this option is fully exercisable on September 21, 2020. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.